Clinical Trials Browser

INDUSTRY × catumaxomab × Genitourinary × Clear all

NCT04799847 2023-02-13

Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine

Phase 1/2 Unknown

Urinary Bladder Neoplasms

NCT04819399 2022-04-05

Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC

Phase 1 Unknown

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms